Reference : Absence de benefice de l'administration intermittente de l'insuline lors d'un traitement...
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/14033
Absence de benefice de l'administration intermittente de l'insuline lors d'un traitement par pompe a perfusion sous-cutanee chez le diabetique de type-1.
French
[fr] Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes
Lilet, Henri mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine nucléaire >]
Krzentowski, G. [> > > >]
Bodson, Arthur [> > > >]
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Lefebvre, Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
1991
Diabète & Métabolisme
Masson
17
3
363-72
Yes (verified by ORBi)
0338-1684
Paris
France
[en] 3-Hydroxybutyric Acid ; Adult ; Blood Glucose/analysis ; Diabetes Mellitus, Type 1/blood/drug therapy ; Drug Administration Schedule ; Fatty Acids, Nonesterified/blood ; Female ; Glycerol/blood ; Humans ; Hydroxybutyrates/blood ; Insulin/blood ; Insulin Infusion Systems ; Kinetics ; Male
[en] Our study is based on two constatations: 1) Hyperinsulinaemia, a possible atherogenic factor, is frequent under continuous subcutaneous insulin infusion. 2) Pulsatile intravenous insulin delivery improve the insulin's hypoglycaemic activity. To test if equivalent metabolic control can be obtained with a reduced intermittent subcutaneous infused insulin dose, we compared nocturnal metabolic control of 8 c-peptide negative type 1 diabetic patients under three experimental conditions: Continuous usual dose test (1.0 +/- 0.1 u/h); Intermittent half dose test (1.0 +/- 0.1 u/h, 30 min/h); Continuous half dose test (0.5 +/- 0.05 u/h) Five parameters were monitored: blood glucose, plasma free insulin and beta-hydroxy-butyrate, free fatty acid and glycerol plasma level. No significant differences were found between intermittent and continuous half-dose tests. We conclude that, in our experimental conditions, intermittent subcutaneous insulin infusion does not reduce the metabolic degradation induced by insulin dose reduction.
http://hdl.handle.net/2268/14033

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.